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1. Introduction
Prevalence of high levels of BMI in both adults and children has been observed in USA
[1,2]. Argentina as well, has experienced marked increases in the prevalence of childhood
overweight/obesity (OW/OB) over the last few decades [3]. Studies in adults have shown
that excess weight is an independent risk factor for end-stage renal disease [4, 5]. Chronic
kidney disease is  a significant public health problem in the United States,  affecting 11%
of  the  U.S.  adult  population  and  it  has  been  associated  with  increased  cardiovascular
morbidity and mortality [6].
Given the high prevalence and the low awareness of chronic kidney disease, it becomes
inevitable to formulate appropriate strategies for the prevention of the chronic kidney disease
to control the escalating healthcare cost [7]. A screening program in communities would detect
previously unidentified persons at high risk for chronic kidney disease in the general popu‐
lation [8]. OB has been shown to be a strong predictor of chronic kidney disease [4,9,10].
Additionally, studies have suggested an association between insulin resistance and chronic
kidney disease [11,12]. A large study performed in a community population in Shanghai,
China, showed that OB, hypertension, and anemia, were positively correlated with the
development of chronic kidney disease [7].
Few studies have examined the significance of BMI, insulin-resistance and hemoglobin, as risk
factors for the development of chronic kidney disease in normal adolescents. The aim of this
study was to determine the association between calculated creatinine clearance (CrC) and risk
factors for chronic kidney disease such as, BMI, insulin resistance (HOMA-IR), and hemoglo‐
bin in healthy adolescents.
© 2013 Hirschler; licensee InTech. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
2. Methods
2.1. Study design and participants
Data were collected cross-sectionally from 195 adolescent boys aged 16.7 ± 1.8 years, age ranged
15-21 years, in an amateur rugby club in the west side of the Buenos Aires suburbs in April
2009. Exclusion criteria included: missing BMI, blood pressure information, known diabetes
or other chronic disease, the use of medication that could alter blood pressure, glucose or lipid
metabolism, and the informed consent not being signed. Of the 207 adolescents recruited, 4
were missing the BMI information and 8 declined to participate. The remaining 195 children
were included. All subjects were examined by the same physician. The study was approved
by the Human Rights Committee of Durand Hospital in Buenos Aires. Each subject and parent
gave written informed consent after an explanation of the study and before the initiation of
the research studies.
Although Argentina is a Spanish-speaking country, the population differs greatly from what
is usually referred to as Hispanic in the U.S. About 85% of the population is of European
descent (largely Spanish and Italian), with the remainder of mixed European and American
Indian (12%) or American Indian (3%) descent [13]. Socio-demographic characteristics
included age, level of education and the presence or absence of a refrigerator and/or a dirt
floor. Questionnaires for socio economic status have been described in detail elsewhere [14].
2.2. Anthropometric measures, stage of puberty and blood pressure
Height  and  weight  were  measured  with  subjects  wearing  light  clothing  and  without
shoes. Weight was measured to the nearest 0.1 kg on a medical balance scale. Height was
measured to the nearest 0.1 cm. with a wall-mounted stadiometer. Adolescents were clas‐
sified as normal weight (BMI< 85%), OW (BMI 85% to < 95%), or OB (BMI > or = 95%) ac‐
cording  to  CDC  norms  [15].  When  participants  were  older  than  18  years  they  were
classified as normal weight (BMI < 25 kg/m2),  OW (25 kg/m2  ≤  BMI < 30 kg/m2),  or  OB
(≥30 kg/m2) according to the adult definition [16]
Waist circumference measurement was taken at the level of the umbilicus and recorded to
0.1cm. A non-elastic flexible tape measure was employed with the subject standing without
clothing covering the waist area. Central OB was defined as waist circumference ≥ 94cm per
international diabetes federation criteria (IDF) [17].
Three separate blood pressure measurements were recorded by a trained technician using a
random-zero sphygmomanometer after the participant was seated at rest for 5 minutes. The
averages of the last 3 measurements of systolic and diastolic blood pressures were used [18].
Hypertension was defined according to IDF criteria [17].
Metabolic syndrome was defined according to IDF criteria [17]. Metabolic syndrome is a
constellation of metabolic abnormalities that predicts premature coronary artery disease.
Recently the IDF [17] developed a simple unified definition for children over 10 years of age.
The IDF definition for adolescents included the presence of ≥3 of the following 5 conditions:
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[1] central OB (waist circumference >94cm), [2] fasting triglycerides ≥150 mg/dL, [3] HDL-C
<40 mg/dL, [4] hypertension with systolic blood pressure ≥ 130 and/or diastolic blood pressure
≥85 mm Hg percentile [5] fasting glucose >100 mg/dL.
The physical examination also included determination of the stage of puberty according to the
criteria of Tanner [19].
2.3. Biochemistry
Baseline blood samples were obtained from subjects while they were fasting for 12 hours, for
measurement of complete blood count (CBC), levels of glucose, insulin, lipid profile and
creatinine. Plasma glucose was obtained by the glucose oxidase technique and serum lipids
were measured with a Hitachi Modular P analyser (Hitachi High Technologies Corp., Tokyo,
Japan). Serum insulin levels were determined by radioimmunoassay (Diagnostic Products,
Los Angeles, CA, USA) and did not cross-react with proinsulin or C-peptide (%CV 5.2-6.8%).
Serum creatinine was obtained by the enzymatic method (Bayer, ID-MS, HPLC).
The following equation for HOMA-IR index was used: fasting insulin (uU/l) x fasting glucose
(mmol/l)/22.5) [20].
2.4. Estimated glomerular filtration rate
Kidney Disease Improving Global Outcome organization [21] recommended the estimation of
glomerular filtration rate, using the simplified equation. Several formulas are widely used in
clinical practice: The Schwartz equation is used and validated for adolescents [22]. The
abbreviated Modification of Diet in Renal Disease and quadratic equation (MDRD) is used for
individuals older than 18 years old [23].The Cockcroft–Gault equation [24] was not used for
analysis because it introduces a major methodological problem. Since weight is already
included in the numerator of the equation, the association between BMI and CrC would be
obvious.
2.5. Data analysis
Chi squared test was used to compare proportions. When more than 20% of the cells had
expected frequencies <5, Fisher's exact test was used. The fit to normal distribution of contin‐
uous variables was assessed using the Shapiro-Wilks test. When comparing two groups with
normally distributed data, a student t test was performed. When comparing more than three
groups and with data that were normally distributed, one-way Analysis of Variance was used
(Student-Newman-Keuls post hoc test ). When the homogeneity of the variances could not be
proven, we used the non-parametric Kruskal Wallis instead of Analysis of Variance, with Dunn
post hoc test. We evaluated the correlation of plasma CrC with components of the metabolic
syndrome using Spearman correlation coefficients. The primary focus of the analysis was to
determine the association between calculated CrC and risk factors for chronic kidney disease.
Multiple linear regression analysis using CrC as the dependent variable was used. In order to
obtain an r squared in each step, a stepwise method was used. P values <0.05 were considered
significant in the two-tailed situation. Data are presented as mean ± SD unless otherwise stated.
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Analyses were done using the SPSS (Chicago, IL) statistical software package SPSS version
10.0 ®.
3. Results
3.1. Physical and metabolic characteristics:
Participants came from a middle-low socioeconomic class, reflected in their parents’ educa‐
tional background, with 51.8% of mothers and 53.3% of fathers having completed an elemen‐
tary school education or less. All of the families had a refrigerator and none had a dirt floor.
All participants were at pubertal or post pubertal stage. Accordingly, clinical and metabolic
characteristics are presented in Table 1.
Mean ±Std. Deviation
Age (years) 16.73 ±1.78
BMI(Kg/m2) 25.20 ±4.99
Waist Circumference (cm) 83.58 ±12.95
Systolic BP(mmHg) 115.90 ±11.59
Diastolic BP(mmHg) 71.16 ±8.56
Hemoglobin (g/dL) 14.76 ±0.911






Cr C(ml/min) 128.44 ±28.16
OB% 24.1% (47/195)
OW % 21.0% (41/195)
Central OB 23.6% (45/191)
Tanner 3 11.3% (20/195)
Tanner 4 32.1% (57/195)
Tanner 5 55.4% (95/195)
BP, blood pressure. Data are mean ±S.D. or percentage.
Table 1. Clinical and metabolic characteristics
Type 2 Diabetes160
3.2. Physical and metabolic characteristics according to the presence of OW/OB
Adolescents were divided by the presence of OW/OB. The prevalence of OB adolescents was
47 (24.1%), and of OW 41 (21.0%). There was no significant difference in age between the
groups. Clinical and metabolic characteristics according to the presence of OW/ OB are
presented in Table 2. Mean values of BMI, triglycerides, systolic blood pressure, diastolic blood
pressure, insulin, and HOMA-IR were significantly higher while HDL-C was significantly
lower in the group of children with OW or OB (Table 2). Mean values of CrC were not
significantly different among normal weight and OW or OB adolescents.
Normal Weight OW OB
N=107 N=41 N=47
Age (c) (years) 16.52 + 1.73 16.45 + 1.81 16.52 + 1.80
BMI(a) (Kg/m2) 21.74 + 2.33 26.14 + 1.41 32.27 + 3.36
WC(a) (cm) 75.05 + 6.88 85.80 + 6.72 101.12 + 8.43
S BP(b) (mm Hg) 113.43 + 9.98 113.59 + 10.63 123.55 + 12.64
D BP(b) (mm Hg) 69.78 + 8.22 68.44 + 6.35 76.70 + 8.70
Hemoglobin (g/dL)
(c) 14.76 + 0.98 14.83 + 0.90 14.74 + 0.74
TG (b) (mg/dl) 75.42 + 33.92 95.44 + 60.67 125.98 + 71.51
Cholesterol (b) 153.65 + 34.93 149.85 + 25.59 171.38 + 34.56
HDL-C(b) (mg/dl) 47.36 + 13.22 42.00 + 9.14 38.47 + 6.92
LDL-C(b) (mg/dl) 94.63 + 34.39 93.24 + 24.36 117.68 + 30.69
Ccr(c) )(ml/min) 131.85 + 27.21 122.24 + 28.88 126.09 + 29.14
HOMA-IR(b) 1.25 + 0.71 1.30 + 0.59 2.68 + 2.07
SBP, systolic blood pressure, DBP diastolic blood pressure, HDL-C, high density lipoprotein; LDL-C, low density lipoprotein;
Data are mean ± standard deviation
(a) Significance found between each group
(b) Significance found in comparison of obese to normal weight and OW
(c) No significant differences found between any of the groups
Table 2. Clinical and Metabolic Characteristics according to the presence of OW/OB.
The prevalence of metabolic syndrome was 6.7% (13/195) overall, 0% in normal weight; 4.9%
in OW and 23.4% in OB (p<0.001]. None had all 5 risk factors. None had diabetes. There was
not a significant difference in the mean values of CrC between children with and without
metabolic syndrome.




Subjects were divided for comparison of mean values of CrC, into four groups according to
hemoglobin quartiles: 1st (12.2–14.1g/dL), 2nd (14.2–14.7 g/dL), 3rd (14.8-15.3 g/dL), and 4th (15.4–
17.6 g/dL). None of the adolescents had anemia (Hb<12g/dL). Mean CrC was significantly
higher in quartile 1 than in quartiles 2, 3 and 4 (Figure 1).
Figure 1. Mean Values of CrC according to Hemoglobin Quartiles
3.4. Insulin resistance quartiles
Subjects were divided into four groups by HOMA-IR quartiles for comparison of their means.
As insulin resistance increased, BMI, waist circumference, systolic blood pressure, triglycer‐
ides and CrC increased significantly from the lowest to the highest quartiles of HOMA-IR
levels (Table 3). There was not a significant difference in age, LDL-C, HDL-C, and total
cholesterol between HOMA-IR quartiles.
3.5. Univariate and multivariate analysis
There was a univariate association (p<0.01) between CrC and age (r=--0.60), Tanner (r=-0.51),
BMI (r = -0.29), waist circumference (r = -0.22), systolic blood pressure (r = -0.18), diastolic blood
pressure (r =- 0.22), hemoglobin (r = -0.39), triglycerides (r = -0.15), insulin (r = 0.25), and HOMA-
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IR (r = 0.24). There was neither a significant correlation between CrC and white leukocytes
count, nor with HDL-C.
When significant factors chosen by univariate analysis were entered in the multiple linear
regression analysis, it showed that age, BMI, hemoglobin and HOMA-IR were significantly
associated with CrC adjusted for Tanner stage, waist circumference, systolic, diastolic blood
pressure, and triglycerides ( r2=0.52) (Table 4). In order to obtain an r2 in each step, a stepwise
method was used. The first step, which incorporated only age, explained 37% of the total
variance. The second step, which included hemoglobin, produced an increase of 6% and the
third step which included BMI, produced an increase of 3%. The fourth step, which included









N=47 N=48 N=48 N=48
Age (years) (e) 16.32 + 1.75 16.92 + 1.73 16.62 + 1.96 16.10 + 1.45
BMI(a) (Kg/m2) 22.77 + 3.36 25.35 + 4.50 24.86 + 4.56 28.12 + 5.87
WC(a) (cm) 76.63 + 8.93 83.69 + 11.85 82.38 + 11.40 92.00 + 14.48
Systolic BP(b)
(mmHg) 111.45 + 9.09 114.85 + 9.80 117.69 + 13.52 119.77 + 12.31
Triglycerides(c)
(mg/dl) 67.17 + 28.89 84.71 + 46.94 91.42 + 46.68 125.46 + 73.76
Cholesterol(e)
(mg/dl) 155.77 + 36.82 150.08 + 32.88 157.04 + 34.28 166.98 + 31.33
HDL-C(e) (mg/dl) 45.87 + 9.16 43.92 + 9.96 44.38 + 17.19 41.92 + 8.98
LDL-C(e) (mg/dl) 99.64 + 35.80 93.06 + 31.88 101.48 + 33.93 107.65 + 30.19
Ccr(c)(ml/min) 122.33 + 19.78 119.16 + 28.22 133.83 + 31.93 137.28 + 27.30
Insulin(mU/l) (a) 3.21 + 1.05 5.46 + 1.03 7.65 + 1.07 14.34 + 7.93
HOMA-IR(a) 0.60 + 0.20 1.08 + 0.14 1.58 + 0.16 3.18 + 1.78
(a) Significance found in comparison of quartile I to II, and quartile IV to I,II &III
(b) Significance found in comparison of quartile I to III & IV
(c) Significance found in comparison of quartile IV to I,II &III
(d) Significance found in comparison of quartile I to III and quartile IV to I,II &III
(e) No significance found between any of the groups
Table 3. Clinical and metabolic patient characteristics according to HOMA-IR quartiles. Analysis by analysis of variance:
mean (± SD)






Age -5.84 1.06 -5.50 <0.001 0.52
BMI -1.86 0.41 -4.49 <0.001
Hb -6.93 1.91 -3.64 <0.001
HOMA-IR 6.40 1.47 4.36 <0.001
Table 4. Multiple Regression Analysis (stepwise method)
Dependent variable: CrC. Adjusted for waist circumference, Tanner stage. systolic blood
pressure, diastolic BP, triglycerides.
4. Discussion
The most important findings in this report were that age, insulin-resistance, BMI, and hemo‐
globin were associated with CrC in normal adolescents. These findings were supported by the
results of the univariate correlations and the multiple regression analysis with the use of lipid
profile, blood pressure, and waist circumference as independent factors. Adolescents with
insulin-resistance had a higher CrC compared to adolescents without insulin-resistance of a
similar age and pubertal development. We also found that mean CrC was significantly higher
in adolescents in the lower hemoglobin quartile than in the other quartiles.
The rise in the prevalence of  OW/OB in adolescents is  one of  the most alarming public
health issues facing the world today. The 2003-2004 US National Health and Nutrition Ex‐
amination  Survey  of  adolescents  aged  12  to  19  years  found that  35% of  children  were
OW/OB [25]. The prevalence of OW/OB in this cohort of Argentinean adolescents (45.1%)
was higher  than the  high rate  of  OW/OB among adolescents  in  the  United States.  This
could be due to the fact that OW/OB adolescents are especially encouraged to practice a
sport.  Furthermore,  bigger adolescents are specially selected for certain positions on the
rugby field due to their size. Therefore, the prevalence of OW/OB in this group of rugby
amateurs could be overrepresented.
Clinical and pathologic characteristics of a distinct nephropathy have emerged independent
of that of diabetic or hypertensive glomerulosclerosis including a silent presentation in OB
individuals [26-28]. Tomaszewski et al. [29] was the first to demonstrate that OB could explain
the relationship between hyperfiltration and BMI. However, as Cockcroft–Gault equation was
used to estimate glomerular filtration rate, it introduced a major methodological problem since
weight was included in the formula [29]. Consistent with this study, several papers showed
that OB was associated with elevated glomerular filtration rate [30-,33]. In contrast several
studies [34,35] noted that glomerular filtration rate in OB patients was lower. The mechanism
could be due to increased fat in the renal helium that may compress renal vessels and paren‐
chyma, decreasing renal blood flow and tubular flow rates [34,35]. Consistent with these
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studies this paper shows a significant inverse association between BMI and glomerular
filtration rate in healthy adolescents. Therefore, increased renal blood flow and hyperfiltration
may not be universal findings in OB individuals. The potential mechanisms involving OB and
CrC are perhaps unknown [10].
A recent retrospective cohort study showed that BMI was an independent predictor of chronic
kidney disease progression on multivariate analysis but no significant difference was observed
between normal weight and OW/OB individuals [36]. Another methodological issue is the
categorization of individuals as OW or OB. Consistent with this fact, though we found that
mean CrC was higher in the normal weight than in OW/ OB adolescents the difference did not
reach a significant level. However, we found a significant inverse association between BMI
and glomerular filtration rate in the univariate and in the multivariate analysis.
Insulin resistance has been implicated as a predictor of renal function [11,37,38]. The National
Health and Nutrition Examination Study (NHANES) III population [11] showed that after
adjustment for multiple confounders, the odds ratios of prevalent kidney disease significantly
increased from the lowest to the highest quartiles of HOMA-IR. Consistent with these studies
we found that CrC increased as HOMA-IR quartiles increased. Our findings are also in
accordance with previous community-based studies in adults [11, 38] which have investigated
the association of insulin resistance and CrC. Impaired insulin sensitivity and hyperinsuline‐
mia have been suggested to contribute to the development of renal injury via a number of
different pathophysiologic pathways. Insulin per se stimulates the expression and activation
of IGF-1, and components of the renin-angiotensin-aldosterone system [39]. These factors have
been shown to promote mitogenic and fibrotic processes in the kidney, such as proliferation
of mesangial cells and extracellular matrix expansion [39]. Moreover, insulin resistance and
hyperinsulinemia are closely associated with oxidative stress [40], which could promote renal
injury via decreased production and availability of nitric oxide [41]
Our study shows that hemoglobin was inversely associated with CrC. Different studies
performed to investigate the risk factors of chronic kidney disease in communities showed
that OB, and anemia, were positively correlated with the development of the disease [7,8]. This
research found that adolescents in the lower quartile of hemoglobin had significantly higher
mean CrC than adolescents in the other quartiles, even if none of the adolescents had anemia.
Consistent with these previous studies we found in the regression analysis that there was a
significant inverse association between CrC and hemoglobin, adjusted by several confounding
factors.
Several limitations of this study should be acknowledged. First, it was a cross-sectional
analysis, and thus, the directionality of the associations could not be established. However,
appropriate analysis of cross-sectional data represent a useful initial step in identifying
relationships between OB and CrC. Secondly, CrC was estimated with serum creatinine and
not with the gold standard measure of renal function [21] Therefore, an incorrect conclusion
may derive from our results. Thirdly, as the sample included only adolescent boys, girls were
not represented. However, the strengths of our study included our amateur rugby club sample,
which was more likely to represent the healthy population, the good response rate of the
adolescents, the measurement of creatinine concentration for all participants by the same
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laboratory and method, and the use of regression models and simultaneous adjustments of
confounding variables.
5. Conclusions
In summary, we have identified BMI, hemoglobin and insulin-resistance as strong and
potentially modifiable risk factors for the development of chronic kidney disease in adoles‐
cents. Therefore, efforts to prevent and treat OB and insulin resistance in the general population
could possibly have a beneficial impact on the incidence, progression and related co-morbid‐
ities and costs of chronic kidney disease. However, further longitudinal studies are needed in
order to shed further light on this issue.
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